Literature DB >> 29466705

Synonymous Mutations at the Beginning of the Influenza A Virus Hemagglutinin Gene Impact Experimental Fitness.

Aneth S Canale1, Sergey V Venev2, Troy W Whitfield3, Daniel R Caffrey4, Wayne A Marasco5, Celia A Schiffer1, Timothy F Kowalik6, Jeffrey D Jensen7, Robert W Finberg4, Konstantin B Zeldovich2, Jennifer P Wang8, Daniel N A Bolon9.   

Abstract

The fitness effects of synonymous mutations can provide insights into biological and evolutionary mechanisms. We analyzed the experimental fitness effects of all single-nucleotide mutations, including synonymous substitutions, at the beginning of the influenza A virus hemagglutinin (HA) gene. Many synonymous substitutions were deleterious both in bulk competition and for individually isolated clones. Investigating protein and RNA levels of a subset of individually expressed HA variants revealed that multiple biochemical properties contribute to the observed experimental fitness effects. Our results indicate that a structural element in the HA segment viral RNA may influence fitness. Examination of naturally evolved sequences in human hosts indicates a preference for the unfolded state of this structural element compared to that found in swine hosts. Our overall results reveal that synonymous mutations may have greater fitness consequences than indicated by simple models of sequence conservation, and we discuss the implications of this finding for commonly used evolutionary tests and analyses.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  deep mutational scanning; experimental evolution; influenza A virus; selection; synonymous mutations

Mesh:

Substances:

Year:  2018        PMID: 29466705     DOI: 10.1016/j.jmb.2018.02.009

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  Molecular analysis of influenza A H1N1pdm09 virus circulating in Madhya Pradesh, India in the year 2017.

Authors:  Salonee Pandey; Mahima Sahu; Varsha Potdar; Pradip Barde
Journal:  Virusdisease       Date:  2018-07-16

2.  Positive epistasis between disease-causing missense mutations and silent polymorphism with effect on mRNA translation velocity.

Authors:  Robert Rauscher; Giovana B Bampi; Marta Guevara-Ferrer; Leonardo A Santos; Disha Joshi; David Mark; Lisa J Strug; Johanna M Rommens; Manfred Ballmann; Eric J Sorscher; Kathryn E Oliver; Zoya Ignatova
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-26       Impact factor: 12.779

3.  Molecular epidemiology survey and characterization of human influenza A viruses circulating among Palestinians in East Jerusalem and the West Bank in 2015.

Authors:  Maysoon Bakri; Monjed Samuh; Maysa Azzeh
Journal:  PLoS One       Date:  2019-03-08       Impact factor: 3.240

4.  Conserved structural RNA domains in regions coding for cleavage site motifs in hemagglutinin genes of influenza viruses.

Authors:  Alexander P Gultyaev; Mathilde Richard; Monique I Spronken; René C L Olsthoorn; Ron A M Fouchier
Journal:  Virus Evol       Date:  2019-08-21

5.  Rolling circle amplification: A high fidelity and efficient alternative to plasmid preparation for the rescue of infectious clones.

Authors:  Jeffrey M Marano; Christina Chuong; James Weger-Lucarelli
Journal:  Virology       Date:  2020-09-28       Impact factor: 3.616

6.  Inferring the distribution of fitness effects in patient-sampled and experimental virus populations: two case studies.

Authors:  Ana Y Morales-Arce; Parul Johri; Jeffrey D Jensen
Journal:  Heredity (Edinb)       Date:  2022-01-05       Impact factor: 3.821

7.  Analyses of HIV proteases variants at the threshold of viability reveals relationships between processing efficiency and fitness.

Authors:  Gily Schneider-Nachum; Julia Flynn; David Mavor; Celia A Schiffer; Daniel N A Bolon
Journal:  Virus Evol       Date:  2021-12-14

8.  How Can We Resolve Lewontin's Paradox?

Authors:  Brian Charlesworth; Jeffrey D Jensen
Journal:  Genome Biol Evol       Date:  2022-07-02       Impact factor: 4.065

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.